Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 12.61% vs 14.61% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 27.17% vs 8.08% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -20.32% vs -5.98% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -50.36% vs 399.64% in Mar 2025
Compare Profit and Loss Results of Bajaj Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
611.00
379.00
232.00
61.21%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
611.00
379.00
232.00
61.21%
Expenditure (Ex Depriciation)
Stock Adjustments
10.00
2.00
8.00
400.00%
Raw Materials Consumed
306.00
181.00
125.00
69.06%
Power & Fuel Cost
31.00
10.00
21.00
210.00%
Employee Cost
62.00
92.00
-30.00
-32.61%
Operating Expenses
57.00
5.00
52.00
1,040.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
13.00
-8.00
-61.54%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
10.00
1.00
9.00
900.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
506.00
329.00
177.00
53.80%
Operating Profit (PBDIT) excl Other Income
104.00
49.00
55.00
112.24%
Other Income
7.00
8.00
-1.00
-12.50%
Operating Profit (PBDIT)
111.00
58.00
53.00
91.38%
Interest
22.00
10.00
12.00
120.00%
Profit before Depriciation and Tax
89.00
48.00
41.00
85.42%
Depreciation
27.00
14.00
13.00
92.86%
Profit Before Taxation & Exceptional Items
62.00
33.00
29.00
87.88%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
28.00
-84.00
112.00
133.33%
Provision for Tax
7.00
-5.00
12.00
240.00%
Profit After Tax
21.00
-79.00
100.00
126.58%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
304.00
197.00
107.00
54.31%
Profit Available for appropriations
325.00
117.00
208.00
177.78%
Appropriations
325.00
117.00
208.00
177.78%
Equity Dividend (%)
30%
10%
20.00
Earnings Per Share
4.98
-2.08
7.06
339.42%
Profit And Loss - Net Sales
Net Sales 611.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.61% vs 14.61% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 104.82 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 27.17% vs 8.08% in Mar 2025
Profit And Loss - Interest
Interest 22.23 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -20.32% vs -5.98% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 21.31 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -50.36% vs 399.64% in Mar 2025
Footer loading
